Antimicrobial Peptide LL-37 Promotes YB-1 Expression, and the Viability, Migration and Invasion of Malignant Melanoma Cells

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2016.5978
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Antimicrobial Peptide LL-37 Participates in the Transcriptional Regulation of Melanoma Cells

Journal of Cancer
Oncology
2016English

Interaction of Antimicrobial Peptide Ll-37 With Lipopolysaccharides

Biophysical Journal
Biophysics
2019English

The Antimicrobial Peptide, LL-37, Inhibits in Vitro Osteoclastogenesis

Journal of Dental Research
Dentistry
2012English

Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats

Anesthesiology
AnesthesiologyPain Medicine
2007English

Antimicrobial Peptide LL-37 Is Bactericidal Against Staphylococcus Aureus Biofilms

PLoS ONE
Multidisciplinary
2019English

Statins Influence Epithelial Expression of the Antimicrobial Peptide LL-37/hCAP-18 Independently of the Mevalonate Pathway

Clinical and Experimental Immunology
AllergyImmunology
2018English

MicroRNA-9 Suppresses the Growth, Migration, and Invasion of Malignant Melanoma Cells via Targeting NRP1

OncoTargets and Therapy
OncologyPharmacology
2016English

miR‑124 Inhibits Proliferation, Migration and Invasion of Malignant Melanoma Cells via Targeting Versican

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy